title: Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.
authors.affiliation: Structural Biochemistry Program, SAIC-Frederick, National Cancer Institute-FCRDC, MD 21702, USA. erickson@ncifcrf.gov
authors.forename: J W
authors.initials: JW
authors.lastname: Erickson
authors.forename: S V
authors.initials: SV
authors.lastname: Gulnik
authors.forename: M
authors.initials: M
authors.lastname: Markowitz
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D006801:Humans; D016879:Salvage Therapy
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors